Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects.

Airway remodeling is a well-recognized feature in patients with chronic asthma. The accumulation in the submucosa of fibrous proteins that are substrates of matrix metalloproteinases (MMP), and the demonstration of increased levels of MMP-9 in bronchoalveolar lavage fluid, prompted us to determine whether there was an imbalance between MMPs and tissue inhibitors of metalloproteinase (TIMP) in such patients. We investigated the presence of TIMPs and other MMPs. TIMP levels were compared with those of all MMPs and inflammatory cytokines. Adults with stable asthma, either untreated or treated with glucocorticoids (GCs), were enrolled. Healthy nonsmokers served as a control population. MMPs and TIMPs were identified through zymography or immunoblotting. TIMPs, MMPs, and cytokines were measured with enzyme immunoassays. TIMP-1 levels were significantly higher in untreated asthmatic subjects than in GC-treated subjects or controls (p < 0.0001), and were far greater than those of MMP-1, MMP-2, MMP-3, and MMP-9 combined. TIMP-2 was undetectable. TIMP-1 levels were correlated with levels of interleukin-6 (p < 0.012) and the number of alveolar macrophages recovered (p < 0.005). This observation has important implications, since an excess of TIMP-1 could lead to airway fibrosis, a hallmark of airway remodelling in patients with chronic asthma.

[1]  J. Bousquet,et al.  Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[2]  W. Hornebeck,et al.  Collagen zymography as a sensitive and specific technique for the determination of subpicogram levels of interstitial collagenase. , 1998, Analytical biochemistry.

[3]  J. Bousquet,et al.  Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. , 1997, American journal of respiratory cell and molecular biology.

[4]  H. Kita,et al.  Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. , 1997, American journal of respiratory cell and molecular biology.

[5]  P. Howarth,et al.  Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. , 1997, American journal of respiratory and critical care medicine.

[6]  A. Casalini,et al.  Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. , 1997, American journal of respiratory and critical care medicine.

[7]  P. O'Byrne,et al.  Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. , 1997, American journal of respiratory cell and molecular biology.

[8]  K. Shirato,et al.  Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. , 1997, American journal of respiratory cell and molecular biology.

[9]  W. Stetler-Stevenson,et al.  Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. , 1997, Analytical biochemistry.

[10]  P. Kovanen,et al.  TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. , 1996, Journal of immunology.

[11]  L. Liotta,et al.  Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. , 1996, The American journal of pathology.

[12]  P. Suter,et al.  Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.

[13]  J. Bousquet,et al.  Bronchial elastic fibers in normal subjects and asthmatic patients. , 1996, American journal of respiratory and critical care medicine.

[14]  C. Delacourt,et al.  Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. , 1996, American journal of respiratory cell and molecular biology.

[15]  C. Delacourt,et al.  Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[16]  R. Sepper,et al.  Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. , 1995, Chest.

[17]  E. Waubant,et al.  T cell gelatinases mediate basement membrane transmigration in vitro. , 1995, Journal of immunology.

[18]  H. Birkedal‐Hansen.  Proteolytic remodeling of extracellular matrix. , 1995, Current opinion in cell biology.

[19]  P. Heinrich,et al.  Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. , 1995, Nucleic acids research.

[20]  J. Bousquet,et al.  Protein content in bronchoalveolar lavage fluid of patients with asthma and control subjects. , 1995, The Journal of allergy and clinical immunology.

[21]  J. Bousquet,et al.  Modulation by interleukin-4 of cytokine release from mononuclear phagocytes in asthma. , 1994, The Journal of allergy and clinical immunology.

[22]  M. Calderón,et al.  Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. , 1994, American journal of respiratory and critical care medicine.

[23]  T. Hayakawa,et al.  Tissue inhibitors of metalloproteinases and their cell growth-promoting activity. , 1994, Cell structure and function.

[24]  T. K. Hunt,et al.  Transforming growth factor beta (TGF-beta) and dexamethasone have direct opposing effects on collagen metabolism in low passage human dermal fibroblasts in vitro. , 1994, Growth factors.

[25]  T. Haahtela,et al.  Airway mucosal inflammation even in patients with newly diagnosed asthma. , 1993, The American review of respiratory disease.

[26]  J. Dayer,et al.  Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. , 1992, The Journal of clinical investigation.

[27]  A. Capron,et al.  Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. , 1991, The Journal of allergy and clinical immunology.

[28]  S. Shapiro,et al.  Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. , 1991, Journal of immunology.

[29]  P. Howarth,et al.  Myofibroblasts and subepithelial fibrosis in bronchial asthma. , 1990, American journal of respiratory cell and molecular biology.

[30]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[31]  T. Sato,et al.  Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. , 1990, Biochemical and biophysical research communications.

[32]  S. Holgate,et al.  SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS , 1989, The Lancet.

[33]  S. Holgate,et al.  Cellular events in the bronchi in mild asthma and after bronchial provocation. , 1989, The American review of respiratory disease.

[34]  J. Heath,et al.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.